XRCC2 and Hereditary breast and ovarian cancer syndrome: Interestingly, we also found mutations at R239, to Trp/Gln/Gly, associated with Breast-ovarian cancer which interacts with Tyr119 in XRCC2, which itself is also annotated as having mutations linked to hereditary cancer-predisposing syndrome.